Published in PLoS One on June 03, 2013
Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol (2013) 0.95
BRAF gene: From human cancers to developmental syndromes. Saudi J Biol Sci (2014) 0.81
Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol (2016) 0.75
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32
Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol (2011) 3.67
K-ras activation generates an inflammatory response in lung tumors. Oncogene (2006) 2.78
Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol (2005) 2.38
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. Int J Cancer (2010) 2.08
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis (2003) 1.98
BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer (2006) 1.68
Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol (2009) 1.57
Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control (2009) 1.52
High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res (2012) 1.32
C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS One (2008) 1.31
Dual roles for immunity in gastrointestinal cancers. J Clin Oncol (2010) 1.31
Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol (2006) 1.30
The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. PLoS One (2008) 1.28
APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest (2011) 1.23
Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer (2010) 1.21
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis. Cancer Chemother Pharmacol (2010) 1.14
Synchronous colorectal cancer. Tech Coloproctol (2004) 1.04
Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum (2008) 1.04
K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia. Cancer Res (2010) 1.02
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis. PLoS One (2009) 1.01
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol (2012) 0.99
Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Am J Gastroenterol (2008) 0.98
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol (2005) 0.98
Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol (2000) 0.93
GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. Cancer Lett (2012) 0.93
Association of C-reactive protein gene polymorphisms and colorectal cancer. Ann Surg Oncol (2011) 0.91
Colorectal cancer with synchronous liver metastases. Br J Surg (2007) 0.88
Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease. Ann Acad Med Singapore (2010) 0.84
C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenet Genomics (2009) 0.83
Autoantibodies to BRAF, a new family of autoantibodies associated with rheumatoid arthritis. Arthritis Res Ther (2010) 0.82
The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol (2007) 0.80
Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese population. PLoS One (2013) 0.77
MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol (2014) 2.13
Isolation of multipotent cells from human term placenta. Stem Cells (2005) 2.03
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist (2007) 1.85
SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology (2011) 1.67
Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells (2006) 1.63
Pneumothorax after bevacizumab-containing chemotherapy: a case report. Jpn J Clin Oncol (2010) 1.62
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol (2005) 1.55
Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. J Cancer Res Clin Oncol (2014) 1.49
The lectin receptor kinase-VI.2 is required for priming and positively regulates Arabidopsis pattern-triggered immunity. Plant Cell (2012) 1.32
Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology (2011) 1.23
Rectal perforation: a life-threatening complication of stapled hemorrhoidectomy: report of a case. Dis Colon Rectum (2003) 1.23
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma. Cancer (2008) 1.20
Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis (2011) 1.17
Expression of beta-F1-ATPase and mitochondrial transcription factor A and the change in mitochondrial DNA content in colorectal cancer: clinical data analysis and evidence from an in vitro study. Int J Colorectal Dis (2008) 1.16
Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer (2006) 1.16
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol (2010) 1.16
Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol (2010) 1.15
High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol (2008) 1.12
Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin Cancer Res (2007) 1.10
Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis (2011) 1.09
How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum (2005) 1.08
Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum (2005) 1.08
Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res (2005) 1.08
Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology (2005) 1.06
A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer. Oncol Rep (2006) 1.06
Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. Cancer Sci (2009) 1.04
Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization. Genes Chromosomes Cancer (2005) 1.04
Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum (2008) 1.04
CIP2A is a predictor of poor prognosis in colon cancer. J Gastrointest Surg (2012) 1.03
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery. Radiat Oncol (2013) 1.02
Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol (2011) 1.01
SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol (2009) 1.00
ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma. Cancer Sci (2009) 1.00
Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis (2009) 1.00
Long-term prognosis of patients with obstructing carcinoma of the right colon. Am J Surg (2004) 0.99
Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis (2007) 0.99
Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells (2007) 0.99
Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors. Opt Express (2009) 0.99
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol (2012) 0.99
CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology (2002) 0.98
Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol (2004) 0.95
Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma. World J Gastroenterol (2005) 0.95
Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. J Surg Res (2003) 0.95
Loss of heterozygosity: an independent prognostic factor of colorectal cancer. World J Gastroenterol (2005) 0.94
Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg (2011) 0.94
The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol (2010) 0.92
Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis (2006) 0.92
Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy. BMC Cancer (2009) 0.91
Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis. Cancer Lett (2012) 0.91
Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis (2010) 0.91
Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats. Anesth Analg (2010) 0.91
Association of C-reactive protein gene polymorphisms and colorectal cancer. Ann Surg Oncol (2011) 0.91
Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC). Transl Res (2007) 0.91
The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg (2013) 0.90
Retained rectal foreign bodies. J Chin Med Assoc (2003) 0.90
Prospective study of the functional results of transanal endoscopic microsurgery. Hepatogastroenterology (2003) 0.90
Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. Biochem Biophys Res Commun (2011) 0.89
Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute. Int J Colorectal Dis (2009) 0.89
Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication. Support Care Cancer (2006) 0.89
Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan. J Biomed Sci (2011) 0.89
The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy. J Surg Oncol (2011) 0.89
The impact of family history on the outcome of patients with colorectal cancer in a veterans' hospital. Int J Colorectal Dis (2009) 0.89
The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer. J Gastrointest Surg (2011) 0.88
Clinicopathologic features and prognostic analysis of MSI-high colon cancer. Int J Colorectal Dis (2011) 0.88
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma. Int J Oncol (2005) 0.87